Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Rawxies founder: ‘I didn’t give up’ on fundraising in KC
Vegan snack manufacturer Rawxies is en route to closing a funding round that will significantly increase its production. The Kansas City-based company has now raised $512,000 of its seed round, which will boost manufacturing of its raw, vegan snacks by roughly 400 percent. Investors thus far include England’s family, Liz and Brian Kelly, the Women’s…
Meet KC’s Cisco Smart City leaders
Kansas City Mayor Sly James announced on Friday 11 people to serve on the city’s Smart City Advisory Board. With a mixture of corporate, non-profit and civic experience, the board will manage and guide policies for Kansas City’s public-private Smart City project. Announced in the summer of 2014, the project will turn downtown into a…
ClaimKit’s Cheatham: listening scored big business
Adaptability is a cornerstone of launching a successful business. Without that — and a willingness to listen — ClaimKit CEO Chris Cheatham said he would’ve been pursuing a much smaller market with his company’s tech product. ClaimKit, which created a document management system for insurance claims professionals, recently pivoted its model to create a collaborative…
Some like it hot: KC named top startup town
You’re hot, Kansas City, and it’s not just your sweltering summer heat. Entrepreneur Magazine recently named Kansas City — Mo. and Kan. — as one of nine “hot startup cities” that are outside of San Francisco and New York City. Although Kansas City is also known for its tech prowess, the magazine largely noted the…